News blog
Akers Biosciences Inc
- BY: Andrew Hore |
- POSTED: 30/09/2009 |
- COMMENTS: Add yours
A delay in a contract to supply the US military with its BreathScan product has led to a fall in revenues at diagnostic products developer Akers Biosciences Inc.
Revenues slumped from $3.43m to $1.18m in the six months to June 2009, and Akers swung from an underlying profit of $251,000 to a loss of $336,000. The first half of 2008 included $733,000 of licensing revenues which were not repeated in the first half of 2009.
It is difficult to assess when the BreathScan alcohol detection system contract will kick in.
Net cash declined but it was still $3.89m at the end of June 2009.
At 23.25p a share, up 0.25p on the day, Akers is valued at £26.4m.
Akers has agreed to supply rapid malaria tests to Ghana.
© 2007 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
- 2.4mNumber of messages posted on SocialGo networks
- $38mCost savings generated by ideas from WalMart staff over a two month period
- 19.4m
Number of people passing through Johannesburg Airport in 2007
- News Blog
- All micro news
Synchronica
Mobile messaging technology provider Synchronica, which is the subject of a contested, all-share bid from rival Myriad AG, has signed a letter of intent with TSX Venture Exchange-quoted Intertainment Media.
DCD Media
AIM-quoted Timeweave has bought convertible loan notes in DCD Media that can convert into a 29.9% stake in the TV programmes producer.
James Cropper
Paper and speciality fibres manufacturer James Cropper is investing $3m in a new manufacturing facility in New York State.
TEG Group
Peter Gyllenhammar has taken his stake in TEG Group to 3.2% following the purchase of 500,000 shares.
- Browse by issue
- All issues
- Popular tags
- All tags
- AIM Micro feeds
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds
|